Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged-release melatonin for insomnia in cancer patients
KCT0003362Phase 4Recruiting
- Sponsor
- Kuhnil Pharmaceutical
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in Insomnia, sponsored by Kuhnil Pharmaceutical. Started Jan 2019; status: recruiting.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on KCT0003362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003362.